HURA - NASDAQ

TuHURA Biosciences, Inc.

HURA·NASDAQ

$2.27

+9.4%

HealthcareBiotechnology

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$144.24M

EPS-0.6300

P/E Ratio-3.60

Earnings Date08/13/2026

hura

Common Stock

Last Annual Value

59.34K

3-Year CAGR

136%

5-Year CAGR

12%

10-Year CAGR

18%

Adjust for Inflation

TuHURA Biosciences, Inc. Competitors Analysis of Common Stock

HURA · NASDAQ

Company	Common Stock	CAGR 3Y	CAGR 5Y	CAGR 10Y
TuHURA Biosciences, Inc. NASDAQ:HURA	59.34K	105.9%	67.3%	15.1%
Cognition Therapeutics, Inc. NASDAQ:CGTX	90.00K	41.2%	32.5%	N/A
Seer, Inc. NASDAQ:SEER	1.00K	0.0%	0.0%	N/A
Context Therapeutics Inc. NASDAQ:CNTX	91.88K	79.2%	41.9%	N/A
Ovid Therapeutics Inc. NASDAQ:OVID	130.00K	22.3%	13.1%	20.8%
Armata Pharmaceuticals, Inc. AMEX:ARMP	364.00K	0.3%	6.1%	8.2%
Inovio Pharmaceuticals, Inc. NASDAQ:INO	69.00K	44.7%	-20.5%	-0.7%
Agenus Inc. NASDAQ:AGEN	353.00K	-55.3%	-32.8%	-8.7%
Seres Therapeutics, Inc. NASDAQ:MCRB	10.00K	-58.0%	-35.8%	-12.9%
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	6.00K	0.0%	8.4%	N/A
VistaGen Therapeutics, Inc. NASDAQ:VTGN	29.00K	60.6%	-30.7%	27.3%

TuHURA Biosciences, Inc. Fair Value Envelope

HURA · NASDAQ

Our analysis suggests that HURA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.265, this represents a potential HIDDEN relative to our calculated worth for TuHURA Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $2.265

Related Guides

Blog Categories

Continue your HURA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.